How fitting it was that ZOLL Medical
Among the more notable accomplishments the company reported in its earnings release were a 43% increase in sales to its North American pre-hospital market and a 23% increase in international sales. These two segments generated nearly 55% of the revenue for the quarter. As a slight offset to these improvements, ZOLL Medical noted that due to military funding challenges, its military sales decreased by $6 million on a year-over-year basis. Fortunately for shareholders, this segment only accounts for 2.2% of the company's total revenue.
Trading at just less than $27 each, ZOLL Medical's shares are a far cry from their 52-week high of $37 in January, but they appear to be headed on the right track. And for Fools with higher thresholds for risk, this small-cap stock might stand to offer more potential for upside growth than some of its large-cap competitors such as Medtronic
For more on the companies mentioned, check out: